Search Page

1

Cite

Share

Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine.

Korenkov D, Isakova-Sivak I, Rudenko L. Korenkov D, et al. Among authors: rudenko l. Expert Rev Vaccines. 2018 Nov;17(11):977-987. doi: 10.1080/14760584.2018.1541407. Epub 2018 Nov 15. Expert Rev Vaccines. 2018. PMID: 30365908 Review.

Cite

Share

2

Cite

Share

A promising inactivated whole-virion SARS-CoV-2 vaccine.

Isakova-Sivak I, Rudenko L. Isakova-Sivak I, et al. Among authors: rudenko l. Lancet Infect Dis. 2021 Jan;21(1):2-3. doi: 10.1016/S1473-3099(20)30832-X. Epub 2020 Oct 15. Lancet Infect Dis. 2021. PMID: 33069282 Free PMC article. No abstract available.

Cite

Share

3

Cite

Share

COVID-19 in Light of Seasonal Respiratory Infections.

Kiseleva I, Grigorieva E, Larionova N, Al Farroukh M, Rudenko L. Kiseleva I, et al. Among authors: rudenko l. Biology (Basel). 2020 Aug 20;9(9):240. doi: 10.3390/biology9090240. Biology (Basel). 2020. PMID: 32825427 Free PMC article. Review.

Cite

Share

4

Cite

Share

Overview of human rhinovirus immunogenic epitopes for rational vaccine design.

Stepanova E, Isakova-Sivak I, Rudenko L. Stepanova E, et al. Among authors: rudenko l. Expert Rev Vaccines. 2019 Sep;18(9):877-880. doi: 10.1080/14760584.2019.1657014. Epub 2019 Aug 21. Expert Rev Vaccines. 2019. PMID: 31416365 No abstract available.

Cite

Share

5

Cite

Share

Prospects of and Barriers to the Development of Epitope-Based Vaccines against Human Metapneumovirus.

Stepanova E, Matyushenko V, Rudenko L, Isakova-Sivak I. Stepanova E, et al. Among authors: rudenko l. Pathogens. 2020 Jun 18;9(6):481. doi: 10.3390/pathogens9060481. Pathogens. 2020. PMID: 32570728 Free PMC article. Review.

Cite

Share

6

Cite

Share

M2e-based universal influenza vaccines: a historical overview and new approaches to development.

Mezhenskaya D, Isakova-Sivak I, Rudenko L. Mezhenskaya D, et al. Among authors: rudenko l. J Biomed Sci. 2019 Oct 19;26(1):76. doi: 10.1186/s12929-019-0572-3. J Biomed Sci. 2019. PMID: 31629405 Free PMC article. Review.

Cite

Share

7

Cite

Share

Oral influenza vaccination-a possible solution for the next pandemic?

Rudenko L, Isakova-Sivak I. Rudenko L, et al. Lancet Infect Dis. 2020 Apr;20(4):385-386. doi: 10.1016/S1473-3099(19)30683-8. Epub 2020 Jan 21. Lancet Infect Dis. 2020. PMID: 31978351 No abstract available.

Cite

Share

8

Cite

Share

Core commitments for field trials of gene drive organisms.

Long KC, Alphey L, Annas GJ, Bloss CS, Campbell KJ, Champer J, Chen CH, Choudhary A, Church GM, Collins JP, Cooper KL, Delborne JA, Edwards OR, Emerson CI, Esvelt K, Evans SW, Friedman RM, Gantz VM, Gould F, Hartley S, Heitman E, Hemingway J, Kanuka H, Kuzma J, Lavery JV, Lee Y, Lorenzen M, Lunshof JE, Marshall JM, Messer PW, Montell C, Oye KA, Palmer MJ, Papathanos PA, Paradkar PN, Piaggio AJ, Rasgon JL, Rašić G, Rudenko L, Saah JR, Scott MJ, Sutton JT, Vorsino AE, Akbari OS. Long KC, et al. Among authors: rudenko l. Science. 2020 Dec 18;370(6523):1417-1419. doi: 10.1126/science.abd1908. Science. 2020. PMID: 33335055 No abstract available.

Cite

Share

9

Cite

Share

Insights into current clinical research on the immunogenicity of live attenuated influenza vaccines.

Isakova-Sivak I, Grigorieva E, Rudenko L. Isakova-Sivak I, et al. Among authors: rudenko l. Expert Rev Vaccines. 2020 Jan;19(1):43-55. doi: 10.1080/14760584.2020.1711056. Epub 2020 Jan 18. Expert Rev Vaccines. 2020. PMID: 31903816 Review.

Cite

Share

10

Cite

Share

Anti-Influenza Effect of Nanosilver in a Mouse Model.

Kiseleva IV, Farroukh MA, Skomorokhova EA, Rekstin AR, Bazhenova EA, Magazenkova DN, Orlov IA, Rudenko LG, Broggini M, Puchkova LV. Kiseleva IV, et al. Among authors: rudenko lg. Vaccines (Basel). 2020 Nov 13;8(4):679. doi: 10.3390/vaccines8040679. Vaccines (Basel). 2020. PMID: 33202939 Free PMC article.

Cite

Share